Literature DB >> 7049977

Reversible deficient prostacyclin release in childhood hemolytic uremic syndrome.

D A Chamone, W C Proesmans, L A Monnens, P Binda ki Muaka, J G Vermylen.   

Abstract

Plasma was taken from infants and children with acute hemolytic uremic syndrome (HUS) or following remission from this disease. The capacity of these plasma to stimulate release of prostacyclin-like activity from "exhausted" rat aorta rings was studied. Plasma from 10 out 12 children in the acute phase of HUS, but from only 3 out of 15 children following remission failed to stimulate prostacyclin release (p less than 0.005). These findings suggest that, for the majority of children, the plasma abnormality in the acute phase of the disease is acquired rather than congenital.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049977

Source DB:  PubMed          Journal:  Int J Pediatr Nephrol        ISSN: 0391-6510


  8 in total

Review 1.  Glomerular fibrin deposition and removal.

Authors:  J M Bergstein
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

2.  [Prevalence of plasma factor deficiency in the Vienna population. Results of a screening study of 1,300 adults].

Authors:  H Sinzinger; J Flores; F Rauscha
Journal:  Klin Wochenschr       Date:  1988-09-01

3.  Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology.

Authors:  C Loirat; E Sonsino; N Hinglais; J P Jais; P Landais; J Fermanian
Journal:  Pediatr Nephrol       Date:  1988-07       Impact factor: 3.714

4.  Prostacyclin production following in vitro mixing of normal with hemolytic-uremic-syndrome serum.

Authors:  R L Siegler; J B Smith; M B Lynch; S F Mohammad
Journal:  West J Med       Date:  1988-07

5.  Prostacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis in children.

Authors:  A N Alam; N M Abdal; M A Wahed; B Rao; C A Kawser; M Hoque; M M Rahaman
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

Review 6.  Prostacyclin in diarrhoea-associated haemolytic uraemic syndrome.

Authors:  C M Taylor; C J Lote
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

7.  Plasmapheresis as a therapeutic measure in hemolytic-uremic syndrome in children.

Authors:  A Gillor; M Bulla; B Roth; K Bussmann; K Schrör; A Tekook; E Gladtke
Journal:  Klin Wochenschr       Date:  1983-04-01

8.  In vitro prostacyclin production in the hemolytic-uremic syndrome.

Authors:  R L Siegler; J B Smith; M B Lynch; S F Mohammad
Journal:  West J Med       Date:  1986-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.